WO2004012802A1 - Inhaler apparatus for mitigating respiratory complaints - Google Patents
Inhaler apparatus for mitigating respiratory complaints Download PDFInfo
- Publication number
- WO2004012802A1 WO2004012802A1 PCT/HU2002/000162 HU0200162W WO2004012802A1 WO 2004012802 A1 WO2004012802 A1 WO 2004012802A1 HU 0200162 W HU0200162 W HU 0200162W WO 2004012802 A1 WO2004012802 A1 WO 2004012802A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- house
- base
- filling
- blocking member
- beak
- Prior art date
Links
- 230000000116 mitigating effect Effects 0.000 title claims abstract description 5
- 230000000241 respiratory effect Effects 0.000 title claims abstract description 5
- 230000000903 blocking effect Effects 0.000 claims abstract description 15
- 150000003839 salts Chemical class 0.000 claims abstract description 14
- 210000003323 beak Anatomy 0.000 claims abstract description 12
- 239000013078 crystal Substances 0.000 claims description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 239000000919 ceramic Substances 0.000 claims description 3
- 230000001737 promoting effect Effects 0.000 claims description 3
- 229920002379 silicone rubber Polymers 0.000 claims description 3
- 239000004945 silicone rubber Substances 0.000 claims description 3
- 239000000341 volatile oil Substances 0.000 claims description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
- 239000012790 adhesive layer Substances 0.000 claims description 2
- 239000001110 calcium chloride Substances 0.000 claims description 2
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims 2
- 239000001175 calcium sulphate Substances 0.000 claims 1
- 235000011132 calcium sulphate Nutrition 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0018—Details of inhalators; Constructional features thereof with exhalation check valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Definitions
- the object of the invention is an inhaler apparatus for mitigating respiratory complaints, comprising a house, salt holder space, filling, aspiration hole, base and blocking member, the base is supplied with bottom holes, the blocking member is supplied with upper holes, and there is a beak between the house and the aspiration hole.
- Patent specification No. HU 213.187 describes an apparatus which contains a swirl chamber in the house containing the active ingredient, and the inlet of the apparatus is tangentially connected to it. The carrying agent of the active ingredient flows in through this inlet, while there is an outlet chunk at the other end of the chamber.
- the apparatus described in patent specification No. HU 210.758 comprises a stationary part and a rotary part, where the rotary part prevents the grains from clumping. The other function of the rotary part is to supply and loosen the active ingredient.
- Patent specification No. HU 171.644 and HU 213.661 describe apparatuses having special mechanisms for supplying the agent to be inhaled.
- WO 01/45777 describes an inhaler apparatus for aspirating blister packed powdered products. Its disadvantage is that the agent quickly runs short from the apparatus, as only one portion can be used at one occasion.
- Patent specification No. HU 220.182 describes an inhaler apparatus suitable for treating asthmatic complaints.
- the apparatus has a plastic house, a storage space, iodous salt crystal filling in the storage space, inlet and outlet openings, a metal screen and a beak.
- the permissive cross section corresponding to at least one inlet opening is larger than the permissive cross section corresponding to the outlet opening.
- the filling is precipitating on the metal screen, and further, if the apparatus is placed on wet table, the water is absorbed into the tank. It is also unfavourable that when the air is breathed out, it can get into the apparatus causing the salt to clump. Salt crystals of grain size smaller than 1.5 mm are especially disposed to clumping.
- the object of the invention is to eliminate the disadvantages of the known constructions, and to develop an inhaler apparatus which contains no separate screen, which is made of natural material, prevents the humid air coming from the lungs get into the apparatus, the filling is ventilated, and if the apparatus is placed on a wet place, the filling does not contact with the wet surface.
- the inhaler apparatus has several advantages. Due to their size, the salt crystals are not disposed to clumping. Due to its light weight, the inhaler can be designed to be a small size portable apparatus as well. It contains no metal screen, so the probability of precipitation of the salt crystals is also reduced. The blow-back of air is prevented by a retaining valve. At the bottom it has a ventilation channel so that the salt crystals are ventilated, and further, its bottom is raised, so it is less exposed to moisture, e.g. if it is left on the kitchen table. Also for this reason the lower openings are smaller than the upper openings.
- the apparatus contains no plastic, the house is made of environment protecting ceramics and is ergonomically designed. Under the house there is a surface promoting the binding of essential oils, which is advantageous for combined therapy.
- the apparatus is cheaper and more economical than the known ones.
- the major advantage of the apparatus is that, as it is experimentally shown, it is even suitable for substituting cave therapy.
- Figure 1 is an axonometric view of the apparatus
- Figure 2 is the rear view of the apparatus
- Figure 3 is a longitudinal section of the apparatus according to plane A-A shown in figure 2,
- Figure 4 is a sectional view of the apparatus according to plane B-B shown in figure 2,
- Figure 5 is the front view of the apparatus
- Figure 6 is the lateral view of the apparatus
- Figure 7 is the bottom view of the apparatus.
- Figure 1 shows the house 1, the grip 2, the filling opening 3, the blocking plug 4, the adhesive layer 5, the ventilating channel 6, the beak 7, the aspiration hole 8, the exhaust opening 9, the hollow 9a, the retaining valve 10, the clamping boss 11, the bearing brim 12, the base 13, and the bottom holes 14.
- the grip 2 is ergonomically designed so as to facilitate grasping.
- the blocking plug 4 and the retaining valve 10 are shown as an exploded view.
- the clamping boss 11 of the retaining valve 10 is stack into the hollow 9a of the exhaust opening 9.
- figure 2 shows the filling opening 3, the beak 7, the exhaust opening 9 and the ventilating channel 6.
- figure 3 shows the aspiration hole 8, the bearing brim 12, the base 13, the salt holder space 16 for the filling 19, and the upper blocking member 17.
- Figure 4 shows the upper blocking member 17 with the upper holes (18) in section.
- Figure 5 shows the house 1, the ventilating channel 6, the beak 7 and the aspiration hole 8.
- figure 6 shows the filling opening 3, the ventilating channel 6 and the beak 7.
- Figure 7 shows the bottom holes 14 and the binding surface 15 of the base 13, the bearing brim 12 and the ventilating channel 6.
- the house 1, the beak 7, the base 13 and the blocking member 17 form one unit, and are made of ceramics with the bottom holes 14 and the upper holes 18 left free.
- the filling 19 is at least 10 grams of salt crystals of grain size between 1,6 and 4,8 mm.
- the preferable composition of the salt crystals is: NaCl 98,7 %, CaCl 2 0, 13 %, CaSO 0, 1 %, MgCl 2 0,028 %, and Fe 2 O 3 0,00056 %.
- the salt crystals may contain traces of iodine and bromine as well.
- the filling 19 is placed in the apparatus through the filling opening 3, and than the blocking plug 4 made of silicone rubber is fixed with two-component resin-based adhesive.
- the apparatus is used for inhalation by taking the beak 7 in the mouth.
- supplementary therapy essential oils are placed on the bottom of the apparatus.
Abstract
The invention relates to an inhaler apparatus for mitigating respiratory complaints, comprising a house, salt holder space, filling, aspiration hole, base, and blocking member, the base is supplied with bottom holes, the blocking member is supplied with upper holes, there is a beak between the house and the aspiration hole. The invention is characterized in that a ventilating channel (6) is formed under the base (13), there is a filling opening (3) in the side of the house (1), and there is an exhaust opening (9) provided with a retaining valve (10) on the beak (7).
Description
Inhaler Apparatus for Mitigating Respiratory Complaints
The object of the invention is an inhaler apparatus for mitigating respiratory complaints, comprising a house, salt holder space, filling, aspiration hole, base and blocking member, the base is supplied with bottom holes, the blocking member is supplied with upper holes, and there is a beak between the house and the aspiration hole.
Several inhaler apparatuses are known in the prior art. The primary purpose of these apparatuses is to facilitate aspiration of powdered pharmaceuticals. Patent specification No. HU 213.187 describes an apparatus which contains a swirl chamber in the house containing the active ingredient, and the inlet of the apparatus is tangentially connected to it. The carrying agent of the active ingredient flows in through this inlet, while there is an outlet chunk at the other end of the chamber. The apparatus described in patent specification No. HU 210.758 comprises a stationary part and a rotary part, where the rotary part prevents the grains from clumping. The other function of the rotary part is to supply and loosen the active ingredient. Patent specification No. HU 171.644 and HU 213.661 describe apparatuses having special mechanisms for supplying the agent to be inhaled.
The common disadvantage of the above constructions is that they contain moving parts promoting movement and accurate supply of the active ingredient, as a result of which the apparatuses are complicated and the probability of failure is high.
Specification No. WO 01/45777 describes an inhaler apparatus for aspirating blister packed powdered products. Its disadvantage is that the agent quickly runs short from the apparatus, as only one portion can be used at one occasion.
Patent specification No. HU 220.182 describes an inhaler apparatus suitable for treating asthmatic complaints. The apparatus has a plastic house, a storage space, iodous salt crystal filling in the storage space, inlet and outlet openings, a metal screen and a beak. Its
characteristic feature is that the permissive cross section corresponding to at least one inlet opening is larger than the permissive cross section corresponding to the outlet opening. It has the disadvantage that the filling is precipitating on the metal screen, and further, if the apparatus is placed on wet table, the water is absorbed into the tank. It is also unfavourable that when the air is breathed out, it can get into the apparatus causing the salt to clump. Salt crystals of grain size smaller than 1.5 mm are especially disposed to clumping.
The object of the invention is to eliminate the disadvantages of the known constructions, and to develop an inhaler apparatus which contains no separate screen, which is made of natural material, prevents the humid air coming from the lungs get into the apparatus, the filling is ventilated, and if the apparatus is placed on a wet place, the filling does not contact with the wet surface.
The fundamental idea of the invention is that if we take the measures described in the principal claim, the result will be better than with the known constructions.
The problem is solved by the invention as described in principal claim 1. The characteristic features of the different embodiments are included in the subclaims.
The inhaler apparatus according to the invention has several advantages. Due to their size, the salt crystals are not disposed to clumping. Due to its light weight, the inhaler can be designed to be a small size portable apparatus as well. It contains no metal screen, so the probability of precipitation of the salt crystals is also reduced. The blow-back of air is prevented by a retaining valve. At the bottom it has a ventilation channel so that the salt crystals are ventilated, and further, its bottom is raised, so it is less exposed to moisture, e.g. if it is left on the kitchen table. Also for this reason the lower openings are smaller than the upper openings.
It is also favourable that the apparatus contains no plastic, the house is made of environment protecting ceramics and is ergonomically designed. Under the house there is a
surface promoting the binding of essential oils, which is advantageous for combined therapy. The apparatus is cheaper and more economical than the known ones. The major advantage of the apparatus is that, as it is experimentally shown, it is even suitable for substituting cave therapy.
In what follows, the invention is described in detail by presenting preferable embodiments, with reference to the accompanying drawings where:
Figure 1 is an axonometric view of the apparatus, Figure 2 is the rear view of the apparatus,
Figure 3 is a longitudinal section of the apparatus according to plane A-A shown in figure 2,
Figure 4 is a sectional view of the apparatus according to plane B-B shown in figure 2,
Figure 5 is the front view of the apparatus, Figure 6 is the lateral view of the apparatus,
Figure 7 is the bottom view of the apparatus.
Figure 1 shows the house 1, the grip 2, the filling opening 3, the blocking plug 4, the adhesive layer 5, the ventilating channel 6, the beak 7, the aspiration hole 8, the exhaust opening 9, the hollow 9a, the retaining valve 10, the clamping boss 11, the bearing brim 12, the base 13, and the bottom holes 14. The grip 2 is ergonomically designed so as to facilitate grasping. The blocking plug 4 and the retaining valve 10 are shown as an exploded view. The clamping boss 11 of the retaining valve 10 is stack into the hollow 9a of the exhaust opening 9.
Besides the house 1, figure 2 shows the filling opening 3, the beak 7, the exhaust opening 9 and the ventilating channel 6. In addition, figure 3 shows the aspiration hole 8, the bearing brim 12, the base 13, the salt holder space 16 for the filling 19, and the upper blocking member 17. Figure 4 shows the upper blocking member 17 with the upper holes (18) in section.
Figure 5 shows the house 1, the ventilating channel 6, the beak 7 and the aspiration hole 8. Besides the house 1, figure 6 shows the filling opening 3, the ventilating channel 6 and the beak 7. Figure 7 shows the bottom holes 14 and the binding surface 15 of the base 13, the bearing brim 12 and the ventilating channel 6.
The house 1, the beak 7, the base 13 and the blocking member 17 form one unit, and are made of ceramics with the bottom holes 14 and the upper holes 18 left free. The filling 19 is at least 10 grams of salt crystals of grain size between 1,6 and 4,8 mm. The preferable composition of the salt crystals is: NaCl 98,7 %, CaCl2 0, 13 %, CaSO 0, 1 %, MgCl2 0,028 %, and Fe2O3 0,00056 %. The salt crystals may contain traces of iodine and bromine as well. The filling 19 is placed in the apparatus through the filling opening 3, and than the blocking plug 4 made of silicone rubber is fixed with two-component resin-based adhesive.
The apparatus is used for inhalation by taking the beak 7 in the mouth. In case of supplementary therapy essential oils are placed on the bottom of the apparatus.
Claims
1. Inhaler apparatus for mitigating respiratory complaints, comprising a house, salt holder space, filling, aspiration hole, base, and blocking member, the base is supplied with bottom holes, the blocking member is supplied with upper holes, there is a beak between the house and the aspiration hole, characterized in that a ventilating channel (6) is formed under the base (13), there is a filling opening (3) in the side of the house (1), and there is an exhaust opening (9) provided with a retaining valve (10) on the beak (7).
2. Apparatus according to claim 1 characterized in that the base (13) and the blocking member (17) are made of the same material with the house (1), preferably made of ceramics, and form an irresolvable unit with the house (1).
3. Apparatus according to claim 1 or claim 2 characterized in that the filling (13) comprises salt crystals containing calcium sulphate, calcium chloride, and at least 90 mass percent sodium chloride, the mass of the filling (13) is not less than 10 grams, and the diameter of the grains is between 1,6 and 4,8 mm.
4. Apparatus according to any of claims 1 - 3 characterized in that the overall size of the upper holes (18) is bigger than the overall size of the bottom holes (14).
5. Apparatus according to any of claims 1 - 4 characterized in that a binding surface (15) is formed on the bottom part of the base (13) promoting the binding of essential oils.
6. Apparatus according to any of claims 1 - 5 characterized in that the filling opening (3) is closed by a blocking plug (4) preferably made of silicone rubber, and the blocking plug (4) is preferably connected to the house (1) by a two-component resin- based adhesive layer.
7. Apparatus according to any of claims 1 - 6 characterized in that the retaining valve (10) is stack into the hollow (9a) of the exhaust opening (9) by a clamping boss (11), and the retaining valve (10) is preferably made of silicone rubber.
8. Apparatus according to any of claims 1 - 7 characterized in that there is a grip (2) formed on the house (1) designed to facilitate grasping.
9. Apparatus according to any of claims 1 - 8 characterized in that there is a bearing brim (12) under the house (1) forming one unit with it, protecting the base (13) from moisture.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2002356346A AU2002356346A1 (en) | 2002-08-05 | 2002-12-23 | Inhaler apparatus for mitigating respiratory complaints |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HUP0202563 | 2002-08-05 | ||
| HU0202563A HU223431B1 (en) | 2002-08-05 | 2002-08-05 | Inhalation device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2004012802A1 true WO2004012802A1 (en) | 2004-02-12 |
Family
ID=89980679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/HU2002/000162 WO2004012802A1 (en) | 2002-08-05 | 2002-12-23 | Inhaler apparatus for mitigating respiratory complaints |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2002356346A1 (en) |
| HU (1) | HU223431B1 (en) |
| WO (1) | WO2004012802A1 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7318435B2 (en) | 2002-03-29 | 2008-01-15 | Dimitrios Pentafragas | Dry powder inhaler |
| WO2009134157A2 (en) * | 2008-03-26 | 2009-11-05 | S.C. Medical Pharma Salt S.R.L. | Inhaler |
| US7854226B2 (en) | 2002-07-31 | 2010-12-21 | Chiesi Farmaceutici S.P.A. | Powder inhaler |
| CN103418079A (en) * | 2013-08-06 | 2013-12-04 | 汪辉 | Purifier combining aromatic therapy and salt therapy |
| US20140096770A1 (en) * | 2012-10-05 | 2014-04-10 | Lily A. Neff | Salt puffer |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2503732A (en) * | 1949-01-28 | 1950-04-11 | Wyeth Corp | Inhalator |
| US2549303A (en) * | 1949-04-20 | 1951-04-17 | Bristol Lab Inc | Inhaler for crystalline pencilllin or the like |
| US2579280A (en) * | 1949-06-25 | 1951-12-18 | Macgregor Instr Company | Inhaler |
| US2642063A (en) * | 1948-07-31 | 1953-06-16 | Frederick M Turnbull | Inhaler |
| GB718287A (en) * | 1950-12-12 | 1954-11-10 | Hans Bruckbauer | Improved device for the evaporation of liquid inhaling substances |
| GB878106A (en) * | 1958-03-03 | 1961-09-27 | Armour & Co | Improvements in or relating to powder dispensers |
| FR2293221A1 (en) * | 1974-12-03 | 1976-07-02 | Fabre Sa Pierre | Inhaler for treating colds and sinusitis - with active principle in capsules released by press. on piston |
| US4141369A (en) * | 1977-01-24 | 1979-02-27 | Burruss Robert P | Noncombustion system for the utilization of tobacco and other smoking materials |
| US5699789A (en) * | 1996-03-11 | 1997-12-23 | Hendricks; Mark R. | Dry powder inhaler |
| WO1998048875A1 (en) * | 1997-04-29 | 1998-11-05 | The Procter & Gamble Company | Method of delivering halotherapy |
| RU2139063C1 (en) * | 1996-02-14 | 1999-10-10 | Червинская Алина Вячеславовна | Method of treating respiratory diseases |
-
2002
- 2002-08-05 HU HU0202563A patent/HU223431B1/en active IP Right Grant
- 2002-12-23 WO PCT/HU2002/000162 patent/WO2004012802A1/en not_active Application Discontinuation
- 2002-12-23 AU AU2002356346A patent/AU2002356346A1/en not_active Abandoned
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2642063A (en) * | 1948-07-31 | 1953-06-16 | Frederick M Turnbull | Inhaler |
| US2503732A (en) * | 1949-01-28 | 1950-04-11 | Wyeth Corp | Inhalator |
| US2549303A (en) * | 1949-04-20 | 1951-04-17 | Bristol Lab Inc | Inhaler for crystalline pencilllin or the like |
| US2579280A (en) * | 1949-06-25 | 1951-12-18 | Macgregor Instr Company | Inhaler |
| GB718287A (en) * | 1950-12-12 | 1954-11-10 | Hans Bruckbauer | Improved device for the evaporation of liquid inhaling substances |
| GB878106A (en) * | 1958-03-03 | 1961-09-27 | Armour & Co | Improvements in or relating to powder dispensers |
| FR2293221A1 (en) * | 1974-12-03 | 1976-07-02 | Fabre Sa Pierre | Inhaler for treating colds and sinusitis - with active principle in capsules released by press. on piston |
| US4141369A (en) * | 1977-01-24 | 1979-02-27 | Burruss Robert P | Noncombustion system for the utilization of tobacco and other smoking materials |
| RU2139063C1 (en) * | 1996-02-14 | 1999-10-10 | Червинская Алина Вячеславовна | Method of treating respiratory diseases |
| US5699789A (en) * | 1996-03-11 | 1997-12-23 | Hendricks; Mark R. | Dry powder inhaler |
| WO1998048875A1 (en) * | 1997-04-29 | 1998-11-05 | The Procter & Gamble Company | Method of delivering halotherapy |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7318435B2 (en) | 2002-03-29 | 2008-01-15 | Dimitrios Pentafragas | Dry powder inhaler |
| US7854226B2 (en) | 2002-07-31 | 2010-12-21 | Chiesi Farmaceutici S.P.A. | Powder inhaler |
| WO2009134157A2 (en) * | 2008-03-26 | 2009-11-05 | S.C. Medical Pharma Salt S.R.L. | Inhaler |
| WO2009134157A3 (en) * | 2008-03-26 | 2009-12-23 | S.C. Medical Pharma Salt S.R.L. | Inhaler |
| US20140096770A1 (en) * | 2012-10-05 | 2014-04-10 | Lily A. Neff | Salt puffer |
| US9764103B2 (en) * | 2012-10-05 | 2017-09-19 | Lily A. Neff | Salt puffer |
| CN103418079A (en) * | 2013-08-06 | 2013-12-04 | 汪辉 | Purifier combining aromatic therapy and salt therapy |
Also Published As
| Publication number | Publication date |
|---|---|
| HU223431B1 (en) | 2004-07-28 |
| AU2002356346A1 (en) | 2004-02-23 |
| HU0202563D0 (en) | 2002-10-28 |
| HUP0202563A2 (en) | 2003-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0271029B1 (en) | Inhaler | |
| AU749292B2 (en) | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament | |
| MX2007012816A (en) | Blister piercing element for dry powder inhaler. | |
| CA2344358A1 (en) | Improved inhaler | |
| EG24839A (en) | Inhaler | |
| US20080078689A1 (en) | Dry powder inhaler | |
| EP1872817A4 (en) | Dry powder aerosolizing inhaler | |
| JP2009511146A (en) | Respiratory protection | |
| WO2004012802A1 (en) | Inhaler apparatus for mitigating respiratory complaints | |
| WO2003103563A2 (en) | Powder inhaler | |
| JPH05123398A (en) | Throat protection inhalation agent and inhalation instrument | |
| CN207584973U (en) | A kind of fluid temperature control smooth breathing filter instrument | |
| JP2004187658A (en) | Pipe for stop smoking | |
| KR100388528B1 (en) | A mask included charcoal | |
| JPH0263019B2 (en) | ||
| KR20170006487A (en) | portable humidifier | |
| KR200306306Y1 (en) | A perfumed exhalation tools of mouth biting | |
| KR20220009708A (en) | Mask | |
| JP2000167056A (en) | Respiratory gas storage device | |
| TWM294832U (en) | Pesticide granules sprayer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |
|
| WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |